Cargando…

Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China

BACKGROUND: Large gap exists between clinical practice and recommended care and large room exists for the improvement of care quality for non-small cell lung cancer (NSCLC) in China. Results of some studies have shown that assessment of care quality can help to make improvement and the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyu, Su, Shaofei, Li, Shouyi, Bao, Han, Zhang, Meiqi, Liu, Dan, Jiang, Hao, Wang, Jiaying, Liu, Meina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579936/
https://www.ncbi.nlm.nih.gov/pubmed/28859609
http://dx.doi.org/10.1186/s12885-017-3602-0
_version_ 1783260810955456512
author Wang, Xinyu
Su, Shaofei
Li, Shouyi
Bao, Han
Zhang, Meiqi
Liu, Dan
Jiang, Hao
Wang, Jiaying
Liu, Meina
author_facet Wang, Xinyu
Su, Shaofei
Li, Shouyi
Bao, Han
Zhang, Meiqi
Liu, Dan
Jiang, Hao
Wang, Jiaying
Liu, Meina
author_sort Wang, Xinyu
collection PubMed
description BACKGROUND: Large gap exists between clinical practice and recommended care and large room exists for the improvement of care quality for non-small cell lung cancer (NSCLC) in China. Results of some studies have shown that assessment of care quality can help to make improvement and the development of quality indicators is deemed as the initial and most essential part. Yet there is no such an indicators system specifically suitable for Chinese health care system. The goal of the study is to set up a group of Chinese quality indicators for NSCLC care and make it the first step towards the improvement of NSCLC care quality in China. METHODS: We constructed a new indicator framework based on the characteristics of NSCLC care and the nature of Chinese health care system. Under the new framework, potential indicators were collected and a 3-round modified Delphi process was conducted by a national multi-disciplinary Expert Panel to develop a set of indicators until they reached the final consensus. RESULTS: A new indicator framework (structure, process, communication, management of symptoms or treatment toxicity and outcome) was developed. Seventy four indicators were extracted from guidelines and relevant literatures as potential indicators; 43 indicators plus 1 suggested indicator were remained after the discussion of Round 1; questionnaires of Round 2 were rated by Expert Panel and 19 indicators met the inclusion criteria and entered Round 3; 2 of the eliminated indicators in Round 2 were retrieved by the Expert Panel at the in-person meeting (Round 3). Therefore, 21 indicators got the final consensus of the Expert Panel. CONCLUSIONS: Guided by the new indicator structure, a set of indicators suitable for Chinese healthcare system was developed and can be utilized to measure and improve the care quality of non-small cell lung cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3602-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5579936
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55799362017-09-07 Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China Wang, Xinyu Su, Shaofei Li, Shouyi Bao, Han Zhang, Meiqi Liu, Dan Jiang, Hao Wang, Jiaying Liu, Meina BMC Cancer Research Article BACKGROUND: Large gap exists between clinical practice and recommended care and large room exists for the improvement of care quality for non-small cell lung cancer (NSCLC) in China. Results of some studies have shown that assessment of care quality can help to make improvement and the development of quality indicators is deemed as the initial and most essential part. Yet there is no such an indicators system specifically suitable for Chinese health care system. The goal of the study is to set up a group of Chinese quality indicators for NSCLC care and make it the first step towards the improvement of NSCLC care quality in China. METHODS: We constructed a new indicator framework based on the characteristics of NSCLC care and the nature of Chinese health care system. Under the new framework, potential indicators were collected and a 3-round modified Delphi process was conducted by a national multi-disciplinary Expert Panel to develop a set of indicators until they reached the final consensus. RESULTS: A new indicator framework (structure, process, communication, management of symptoms or treatment toxicity and outcome) was developed. Seventy four indicators were extracted from guidelines and relevant literatures as potential indicators; 43 indicators plus 1 suggested indicator were remained after the discussion of Round 1; questionnaires of Round 2 were rated by Expert Panel and 19 indicators met the inclusion criteria and entered Round 3; 2 of the eliminated indicators in Round 2 were retrieved by the Expert Panel at the in-person meeting (Round 3). Therefore, 21 indicators got the final consensus of the Expert Panel. CONCLUSIONS: Guided by the new indicator structure, a set of indicators suitable for Chinese healthcare system was developed and can be utilized to measure and improve the care quality of non-small cell lung cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3602-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-31 /pmc/articles/PMC5579936/ /pubmed/28859609 http://dx.doi.org/10.1186/s12885-017-3602-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Xinyu
Su, Shaofei
Li, Shouyi
Bao, Han
Zhang, Meiqi
Liu, Dan
Jiang, Hao
Wang, Jiaying
Liu, Meina
Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China
title Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China
title_full Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China
title_fullStr Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China
title_full_unstemmed Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China
title_short Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China
title_sort development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579936/
https://www.ncbi.nlm.nih.gov/pubmed/28859609
http://dx.doi.org/10.1186/s12885-017-3602-0
work_keys_str_mv AT wangxinyu developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT sushaofei developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT lishouyi developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT baohan developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT zhangmeiqi developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT liudan developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT jianghao developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT wangjiaying developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina
AT liumeina developmentofqualityindicatorsfornonsmallcelllungcancercareafirststeptowardassessingandimprovingqualityofcancercareinchina